Shengnan Li

863 total citations
30 papers, 549 citations indexed

About

Shengnan Li is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shengnan Li has authored 30 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shengnan Li's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer Cells and Metastasis (3 papers). Shengnan Li is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer Cells and Metastasis (3 papers). Shengnan Li collaborates with scholars based in China, Australia and Hong Kong. Shengnan Li's co-authors include Danyi Mao, Parikshit Asutosh Khadaroo, Lihu Gu, Zefeng Shen, Derry Minyao Ng, Ping Chen, Liming Sun, Haofei Li, Bo Yang and Lin Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and Hepatology.

In The Last Decade

Shengnan Li

30 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengnan Li China 13 165 149 86 68 65 30 549
Falin Chen China 13 201 1.2× 53 0.4× 40 0.5× 39 0.6× 50 0.8× 43 505
Qian Liang China 13 197 1.2× 55 0.4× 20 0.2× 59 0.9× 99 1.5× 69 661
Xiangzhen Liu China 15 183 1.1× 178 1.2× 41 0.5× 80 1.2× 37 0.6× 40 665
Xin Cheng China 19 207 1.3× 133 0.9× 59 0.7× 114 1.7× 89 1.4× 60 853
Jae‐Hwan Jeong South Korea 19 401 2.4× 124 0.8× 50 0.6× 50 0.7× 33 0.5× 37 953
Yun Cao China 17 337 2.0× 74 0.5× 91 1.1× 178 2.6× 51 0.8× 32 827
Haibin Hao China 14 336 2.0× 65 0.4× 48 0.6× 63 0.9× 48 0.7× 28 607
Jian Tang China 14 286 1.7× 96 0.6× 34 0.4× 39 0.6× 30 0.5× 48 586
Yiwei Shen China 13 190 1.2× 45 0.3× 83 1.0× 32 0.5× 65 1.0× 50 653
K. Noda Japan 14 315 1.9× 59 0.4× 68 0.8× 43 0.6× 58 0.9× 28 663

Countries citing papers authored by Shengnan Li

Since Specialization
Citations

This map shows the geographic impact of Shengnan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Li more than expected).

Fields of papers citing papers by Shengnan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengnan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Li. The network helps show where Shengnan Li may publish in the future.

Co-authorship network of co-authors of Shengnan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shengnan Li. A scholar is included among the top collaborators of Shengnan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengnan Li. Shengnan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Zhiheng, et al.. (2025). Deciphering the tumor immune microenvironment: single-cell and spatial transcriptomic insights into cervical cancer fibroblasts. Journal of Experimental & Clinical Cancer Research. 44(1). 194–194. 5 indexed citations
2.
3.
Li, Shengnan, Han Xia, Zeyu Wang, et al.. (2023). Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC. Hepatology. 78(4). 1079–1091. 43 indexed citations
4.
Li, Shengnan, et al.. (2023). 16S rRNA and transcriptome analysis of the FOS-mediated alleviation of Aeromonas hydrophila-induced intestinal damage in Megalobrama amblycephala. International Journal of Biological Macromolecules. 253(Pt 4). 127040–127040. 5 indexed citations
5.
Liu, Weishuai, Xiaozhou Yu, Yixing Feng, et al.. (2022). CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism. Advanced Science. 10(6). e2206335–e2206335. 22 indexed citations
6.
Wang, Zeyu, Jianbiao Li, Xiaoling Guo, et al.. (2022). Esophageal variceal ligation plus sclerotherapy vs. ligation alone for the treatment of esophageal varices. Frontiers in Surgery. 9. 928873–928873. 2 indexed citations
7.
He, Yanling, et al.. (2022). Doublecortin-like kinase 2 promotes breast cancer cell invasion and metastasis. Clinical & Translational Oncology. 25(4). 1102–1113. 3 indexed citations
8.
Li, Shengnan, Lu Yang, Tiansuo Zhao, et al.. (2022). Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer. Frontiers in Oncology. 12. 841819–841819. 11 indexed citations
9.
Sun, Xuejun, Qianggong Zhang, Guoshuai Zhang, et al.. (2022). Melting Himalayas and mercury export: Results of continuous observations from the Rongbuk Glacier on Mt. Everest and future insights. Water Research. 218. 118474–118474. 14 indexed citations
10.
Huang, Xiaolan, Laurence Don Wai Luu, Nan Jia, et al.. (2022). Multi-Platform Omics Analysis Reveals Molecular Signatures for Pathogenesis and Activity of Systemic Lupus Erythematosus. Frontiers in Immunology. 13. 833699–833699. 19 indexed citations
11.
Li, Shengnan, Xin Li, Xiaojie Li, et al.. (2021). Role of the Preoperative Circulating Tumor DNA KRAS Mutation in Patients With Resectable Pancreatic Cancer. Pharmacogenomics. 22(11). 657–667. 4 indexed citations
12.
Zhang, Tingting, Jing Sun, Liang Xu, et al.. (2021). The complete mitochondrial genome of Euonymus alatus (celastraceae, Euonymus L.). SHILAP Revista de lepidopterología. 6(1). 182–184. 4 indexed citations
13.
Zhang, Dan, Shuyang Wang, Lingjie Zhang, et al.. (2020). VCAM1 Promotes Tumor Cell Invasion and Metastasis by Inducing EMT and Transendothelial Migration in Colorectal Cancer. Frontiers in Oncology. 10. 1066–1066. 71 indexed citations
14.
Chen, Jingjie, Shengnan Li, Qigu Yao, et al.. (2020). The efficacy and safety of combined immune checkpoint inhibitors (nivolumab plus ipilimumab): a systematic review and meta-analysis. World Journal of Surgical Oncology. 18(1). 150–150. 37 indexed citations
15.
Gu, Lihu, Nannan Du, Qiong Jin, et al.. (2020). Magnitude of benefit of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for malignant tumor: A meta-analysis. Critical Reviews in Oncology/Hematology. 147. 102888–102888. 16 indexed citations
16.
Li, Shengnan, Zhen Li, Xinyan Zhao, et al.. (2019). RNA-Seq-based transcriptomic profiling of primary interstitial cells of Cajal in response to bovine viral diarrhea virus infection. Veterinary Research Communications. 43(3). 143–153. 15 indexed citations
17.
18.
Li, Shengnan, Shu Wang, Raghavan Murugan, et al.. (2018). Donor biomarkers as predictors of organ use and recipient survival after neurologically deceased donor organ transplantation. Journal of Critical Care. 48. 42–47. 8 indexed citations
19.
Li, Shengnan, Zhanqiong Zhong, Xi Hu, et al.. (2017). Lentivirus-mediated inhibition of AQP4 accelerates motor function recovery associated with NGF in spinal cord contusion rats. Brain Research. 1669. 106–113. 9 indexed citations
20.
Li, Shengnan & Ding Zhang. (2014). Recent progress of adult orthodontic treatment.. PubMed. 36(6). 675–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Falin Chen Breakdown of academic impact, for papers by Qian Liang Breakdown of academic impact, for papers by Xiangzhen Liu Breakdown of academic impact, for papers by Xin Cheng Breakdown of academic impact, for papers by Jae‐Hwan Jeong Breakdown of academic impact, for papers by Yun Cao Breakdown of academic impact, for papers by Haibin Hao Breakdown of academic impact, for papers by Jian Tang Breakdown of academic impact, for papers by Yiwei Shen Breakdown of academic impact, for papers by K. Noda
Rankless by CCL
2026